Louisville, CO, June 7, 2006, GlobeImmune, Inc. today announced the initiation of a randomized, placebo-controlled, multi-center Phase 2 clinical trial of GI-4000, GlobeImmune’s therapeutic vaccine for the treatment of patients with early-stage pancreas cancer. The primary goal of the study … Continue reading
GlobeImmune Initiates Phase 2 Trial for Pancreas Cancer
June 08, 2006